Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Fund News: Nelson Peltz, David Einhorn, D.E. Shaw

Page 1 of 2

DuPont’s Weak Results, Forecast Seen Providing Ammo To Peltz (Reuters)
DuPont’s weak quarterly sales and lowered annual profit forecast is expected to provide fresh ammunition to Nelson Peltz in his campaign to split up the chemical maker. Peltz’s hedge fund Trian Fund Management has for months criticized DuPont’s underperformance, alleging that the company has repeatedly failed to meet financial targets. Trian, DuPont’s fifth-largest shareholder with a 2.7 percent stake, launched a proxy battle in January for four board seats, including one for Peltz. DuPont has said it could accommodate one of Trian’s nominees, but not Peltz himself.


Einhorn’s Greenlight Capital Buys into GM Again (Reuters)
Hedge fund manager David Einhorn‘s Greenlight Capital has taken a new stake in General Motors Co, nearly a year after selling off it position in the automaker, the firm said in a letter to clients on Monday seen by Reuters. The $11 billion fund believes General Motors has put behind it the impact of recalling more than 2.5 million vehicles in 2014 because of ignition switch problems. It expects GM to begin its $5 billion share buyback soon. Greenlight has been closely watched by investors ever since Einhorn bet against Lehman Brothers months before the investment bank crumbled in 2008.

Hedge Fund Push on Swaps Trades Hits Snag With CFTC’s Giancarlo (Bloomberg)
Hedge fund lobbying hasn’t persuaded a key U.S. regulator that the government should step in to curb Wall Street banks’ power over the $700 trillion swaps market. At issue is a requirement that customers disclose their identities when they buy and sell derivatives on some swap-execution facilities. D.E. Shaw & Co. and Citadel LLC want the Commodity Futures Trading Commission to end the practice, which they say gives banks access to proprietary-investing strategies and discourages trading.

Ex-Lansdowne Partner Kirk To Join Forces With $4 Billion Pelham Capital (Reuters)
Stephen Kirk, who left hedge fund manager Lansdowne Partners last year, has dropped a plan to launch his own independent company and will instead join forces with a $4 billion firm run by a former colleague, a letter to investors showed. Kirk, 45, a former partner at Lansdowne, was in the process of setting up Campden Square Capital in London, aiming to start business with more than $200 million in one of the region’s larger 2015 launches, sources told Reuters in March.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!